advertisement
14 Costing studies; pharmacoeconomics (12)
Showing records 1 to 12
Display all abstracts in classification 14 Costing studies; pharmacoeconomics
Search within classification 14 Costing studies; pharmacoeconomics20531 Costs and effectiveness of travoprost versus a dorzolamide + timolol fixed combination in first-line treatment of glaucoma: Analysis conducted on the United Kingdom General Practitioner Research Database
Lafuma A; Berdeaux G
Current Medical Research and Opinion 2007; 23: 3009-3016
20692 Costs of vision impairment: Present and future issues
Keeffe JE
Expert Review of Pharmacoeconomics and Outcomes Research 2007; 7: 523-527
20689 Pharmacoeconomic analysis of prostaglandin and prostamide therapy for patients with glaucoma or ocular hypertension.
Frenkel RE; Frenkel M; Toler A
BMC Ophthalmology 2007; 7: 16
20310 Prostaglandin analogues for ophthalmic use: a cost-effectiveness analysis
Lachaine J; Hodge WG; Steffensen I; Murray C; Barnes D; Foerster V; Ducruet T; Mensinkai S
Canadian Journal of Ophthalmology 2008; 43: 33-41
20643 Assessment of the cost effectiveness of travoprost versus latanoprost as single agents for treatment of glaucoma in France
Payet S; Denis P; Berdeaux G; Launois R
Clinical Drug Investigation 2008; 28: 183-198
20392 Direct costs of blindness experienced by patients enrolled in managed care
Frick KD; Walt JG; Chiang TH; Doyle JJ; Stern LS; Katz LM; Dolgitser M; Hendlish SK
Ophthalmology 2008; 115: 11-17
20322 The costs of treating glaucoma with combinations of topical drugs in Spain
Neymark N; Buchholz P; Honrubia F; Kobelt G
European Journal of Ophthalmology 2008; 18: 52-59
20660 The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: A systematic review and economic evaluation
Burr JM; Mowatt G; Hernandez R; Siddiqui MAR; Cook J; Lourenco T; Ramsay C; Vale L; Fraser C; Azuara-Blanco A
Health Technol Assess 2007; 11: iii-170
20530 Estimated first-year costs of prostaglandin analogs with/without adjunctive therapy for glaucoma management: A United States perspective
Schmier JK; Covert DW; Robin AL
Current Medical Research and Opinion 2007; 23: 2867-2875
20827 Cost-effectiveness of early detection and treatment of ocular hypertension and primary open-angle glaucoma by the ophthalmologist
Peeters A; Schouten JS; Webers CA; Prins MH; Hendrikse F; Severens JL
Eye 2008; 22: 354-362
20389 Cost-effectiveness of treating ocular hypertension
Stewart WC; Stewart JA; Nassar QJ; Mychaskiw MA
Ophthalmology 2008; 115: 94-98
20341 Cost analysis of glaucoma medications
Rylander NR; Vold SD
American Journal of Ophthalmology 2008; 145: 106-113
